Dekervel J - Search Results

1

Not All BRAF-Mutant Metastatic Colorectal Cancers Are Identical: Distinct Clinical Consequences of ^non-V600 BRAF Mutations.

Van Cutsem E, Dekervel J. Van Cutsem E, et al. Among authors: dekervel j. J Clin Oncol. 2017 Aug 10;35(23):2598-2599. doi: 10.1200/JCO.2017.72.7057. Epub 2017 May 16. J Clin Oncol. 2017. PMID: 28510493 No abstract available.

2

Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth.

van Malenstein H, Dekervel J, Verslype C, Van Cutsem E, Windmolders P, Nevens F, van Pelt J. van Malenstein H, et al. Among authors: dekervel j. Cancer Lett. 2013 Feb 1;329(1):74-83. doi: 10.1016/j.canlet.2012.10.021. Epub 2012 Oct 27. Cancer Lett. 2013. PMID: 23111106

3

Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patients.

Dekervel J, Hompes D, van Malenstein H, Popovic D, Sagaert X, De Moor B, Van Cutsem E, D'Hoore A, Verslype C, van Pelt J. Dekervel J, et al. Clin Cancer Res. 2014 Apr 15;20(8):2159-68. doi: 10.1158/1078-0432.CCR-13-2958. Epub 2014 Jan 31. Clin Cancer Res. 2014. PMID: 24486594 Free article.

4

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

Verstraete M, Debucquoy A, Dekervel J, van Pelt J, Verslype C, Devos E, Chiritescu G, Dumon K, D'Hoore A, Gevaert O, Sagaert X, Van Cutsem E, Haustermans K. Verstraete M, et al. Among authors: dekervel j. Br J Cancer. 2015 Apr 14;112(8):1314-25. doi: 10.1038/bjc.2015.93. Epub 2015 Mar 17. Br J Cancer. 2015. PMID: 25867261 Free PMC article.

5

A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma.

Dekervel J, Popovic D, van Malenstein H, Windmolders P, Heylen L, Libbrecht L, Bulle A, De Moor B, Van Cutsem E, Nevens F, Verslype C, van Pelt J. Dekervel J, et al. Transl Oncol. 2016 Apr;9(2):139-146. doi: 10.1016/j.tranon.2016.02.003. Transl Oncol. 2016. PMID: 27084430 Free PMC article.

6

Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response.

Dekervel J, Bulle A, Windmolders P, Lambrechts D, Van Cutsem E, Verslype C, van Pelt J. Dekervel J, et al. Transl Oncol. 2017 Feb;10(1):59-69. doi: 10.1016/j.tranon.2016.11.008. Epub 2016 Dec 15. Transl Oncol. 2017. PMID: 27987431 Free PMC article.

7

Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts.

Bulle A, Dekervel J, Libbrecht L, Nittner D, Deschuttere L, Lambrecht D, Van Cutsem E, Verslype C, van Pelt J. Bulle A, et al. Among authors: dekervel j. Am J Transl Res. 2019 Feb 15;11(2):765-779. eCollection 2019. Am J Transl Res. 2019. PMID: 30899378 Free PMC article.

8

Al¹⁸F-NOTA-octreotide: first comparison with ⁶⁸Ga-DOTATATE in a neuroendocrine tumour patient.

Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Among authors: dekervel j. Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399. doi: 10.1007/s00259-019-04425-1. Epub 2019 Jul 31. Eur J Nucl Med Mol Imaging. 2019. PMID: 31367905 No abstract available.

9

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A, Tarpgaard LS, Braun M, Gollerkeri A, Keir C, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J. Kopetz S, et al. Among authors: dekervel j. N Engl J Med. 2019 Oct 24;381(17):1632-1643. doi: 10.1056/NEJMoa1908075. Epub 2019 Sep 30. N Engl J Med. 2019. PMID: 31566309 Clinical Trial.

10

Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of ¹⁷⁷Lu-DOTATATE PRRT.

Medaer E, Verslype C, Van Cutsem E, Dekervel J, Clement PM, Nackaerts K, Laenen A, Gheysens O, Goffin K, Jentjens S, Van Laere K, Deroose CM. Medaer E, et al. Among authors: dekervel j. Acta Oncol. 2020 Jun;59(6):644-651. doi: 10.1080/0284186X.2020.1723161. Epub 2020 Feb 8. Acta Oncol. 2020. PMID: 32036716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page